Crea il mio profilo
Accesso pubblico
Visualizza tutto27 articoli
1 articolo
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Peter GoosKU LeuvenEmail verificata su biw.kuleuven.be
- Martina VandebroekKU LeuvenEmail verificata su kuleuven.be
- Jeroen LuytenLeuven Unit for Health Technology Assessment Research, KU LeuvenEmail verificata su kuleuven.be
- Bradley JonesPrincipal at AdsurgoEmail verificata su adsurgo.com
- Philippe BeutelsProfessor at Vaccine & Infectious Disease Institute, University of Antwerp, BelgiumEmail verificata su uantwerpen.be
- Guido ErreygersProfessor of Economics, University of AntwerpEmail verificata su uantwerpen.be
- Ann VerhetselProfessor of Economic Geography, University of AntwerpEmail verificata su uantwerpen.be
- Lander WillemUniversity of AntwerpEmail verificata su uantwerpen.be
- Frederik VerelstDirector, Vaccines Value Evidence / Health Outcomes, GSKEmail verificata su gsk.com
- G. Ardine de WitUniversity Medical Centre Utrecht & National Institute of Public Health, the NetherlandsEmail verificata su rivm.nl
- Sandy TubeufUniversité Catholique de LouvainEmail verificata su uclouvain.be
- Niek MouterAssociate professor Delft University of TechnologyEmail verificata su tudelft.nl
- Eddy Van de VoordeUniversiteit AntwerpenEmail verificata su uantwerpen.be
- Job van ExelErasmus University RotterdamEmail verificata su eshpm.eur.nl
- Toon ZijlstraSenior ResearcherEmail verificata su minienw.nl
- Marion CollewetLeiden UniversityEmail verificata su law.leidenuniv.nl
- Maarten van WijhePost-doctoral fellow, University of RoskildeEmail verificata su ruc.dk
- Daniel Palhazi CuervoSINTEF DigitalEmail verificata su sintef.no
- Albert Jan van HoekHealth economist / Infectious disease modeller, RIVMEmail verificata su rivm.nl
- Jeroen CantUniversity of AntwerpEmail verificata su uantwerpen.be